|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61P 31/14 | |
| A61K 31/40 | |||
| C07D 207/27 | |||
| C07D 207/452 | |||
| C07D 295/00 |
| (11) | Patento numeris | 1505963 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03731248.5 |
| Europos patento paraiškos padavimo data | 2003-05-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2005-02-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-04-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2003/015755 |
| Data | 2003-05-20 |
| (87) | Numeris | WO 2003/099274 |
| Data | 2003-12-04 |
| (30) | Numeris | Data | Šalis |
| 382055 P | 2002-05-20 | US |
| (72) |
WANG, Xiangdong, Alan, US
SUN, Li-Quang, US
SIT, Sing-Yuen, US
SIN, Ny, US
SCOLA, Paul, Michael, US
HEWAWASAM, Piyasena, US
GOOD, Andrew, Charles, US
CHEN, Yan, US
CAMPBELL, Jeffrey, Allen, US
|
| (73) |
Bristol-Myers Squibb Company,
Route 206 and Province Line Road P.O. Box 4000, Princeton NJ 08543-4000,
US
|
| (54) | HEPATITIS C VIRUS INHIBITORS |
| HEPATITIS C VIRUS INHIBITORS |